FAQ on HPV
This page is a selection of different questions that Jo's Cervical Cancer Trust has received about HPV. The answers have been reviewed by Jo's medical advisers.
No. Some HPVs cause non-cancerous skin warts that commonly appear on the hands and feet.
Around 40 HPV types affect the genital area and these are divided into those which have no risk for cervical cancer (called low risk) and those which can cause cancer (called high risk). High risk HPV can cause cancer of the cervix, vagina, anus, vulva, penis and some head and neck cancers. High risk types – the types most likely to cause cervical cancer include types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68. Types 16 and 18 cause 70% of all cervical cancers. Low risk HPV types, such as HPV 6 and 11, cause non-cancerous genital warts.
Anybody who has ever been sexually active is at risk of contracting HPV. Genital HPV is transmitted primarily by genital-to-genital skin contact, anal intercourse and occasionally oral sex. The time from exposure to the virus to the development of warts or cervical disease is highly variable and the virus can remain dormant in some people for long periods of time. Often it is not possible to determine exactly when or from whom the infection originated. HPV is classed as a sexually transmitted virus. It is more common in young, sexually active people, with the peak prevalence in women usually occurring between the ages of 16 and 25.
The risk of infection increases with the number of sexual partners and individuals who have had multiple sexual partners or whose partners have had multiple partners. However, having HPV is not an indication of promiscuity or infidelity. You can contract HPV on your first sexual encounter. The infection rate in men has not been evaluated to the same extent as in women but is likely to follow the same pattern as for women.
HPV infections are very common and the majority of infected individuals will have no obvious signs or symptoms. Therefore, it is very difficult to tell whether an individual is infected and the only way to entirely avoid the possibility of being exposed to HPV is abstinence. This is unlikely to be a popular option for most people, although people should be reminded that it is primarily a sexually transmitted infection and the risk will therefore be reduced if you and your partner have had few sexual partners and have avoided casual sex.
You can reduce your risk by the practising the following:
- Safe sex: Practising safe sex through the use of condoms can help reduce the risk of being infected with HPV but it will not completely eradicate the risk as HPV lives on the skin in and around the whole genital area . Genital HPV in men affects the skin of the penis, scrotum, anus, and rectum . In women, it affects the vulva (area outside the vagina), the linings of the vagina, cervix, and rectum.
- Leading a healthy lifestyle: Keep your immune system – your body’s natural defence against disease and infection – strong. A weakened immune system could mean that your risk of cervical cancer is higher than average.
- Not smoking: Smoking stops your body’s immune system from working properly, leaving you more likely to develop infections which do not clear up and therefore increasing your chance of developing cervical cancer .
- Ask your doctor about HPV vaccination.
Smoking can increase your risk of developing persistent HPV infection and also has an impact on the cervical cells. By leading a healthy lifestyle, you can reduce the risk of persistent infection and cell changes. Eating healthily, exercising, not taking up or stopping smoking can all help to prevent cervical abnormalities through keeping your immune system healthy.
The majority of women clear the infection through their immune systems but for those who do not, regular cervical screening can pick up abnormalities in cervical cells before a cancer develops. These abnormal cells can then be removed and in the majority of cases this is highly successful. In a small minority of women, changes occur more rapidly, in the interval between cervical screening, or occasionally the changes are not detected by screening.
No. Cancer and genital warts are caused by different types of HPV, so having genital warts does not mean that you are more likely to get cancer. There are about 100 types of HPV, the majority of which do not cause any health problems. Research has identified specific HPV types that are 'high risk' and 'low risk' for cervical cancer. The most common types that cause cervical cancer are high risk HPV types 16 and 18 while the 'low risk' types that cause genital warts are HPV types 6 and 11.
HPV has been linked to the following cancers: cancer of the penis, anal cancer, vaginal cancer, cancer of the vulva. Some but not all mouth and throat cancers are also caused by HPV.
HPV affects mucous skin cells and this means you can have an HPV infection in the mouth, throat, anus, and genital areas. HPV can infect both men and women. As with cervical cancer, HPV can cause abnormal cells to develop and this can in time lead to cancer, however, this is very rare.
Unfortunately, we don’t have a definite answer to this question. In theory, if you and your partner have been infected with HPV, you should be immune to that type and so re-infection should not occur. However, studies have shown that natural immunity to HPV is poor, and women can be reinfected with the same virus type  . So in some cases the answer will be yes, in others no.
Make sure you keep healthy, so that your immune system is able to fight off the virus. In particular, don't smoke, or give up smoking if you do smoke. Smoking has been shown to double your risk of cervical cancer.
Condoms can help prevent infection with HPV, but they don’t guarantee protection.
There is some evidence that having the HPV vaccine, even after you have had an infection with HPV, might offer protection from further infections in the future. However this is still being investigated and more research is needed.  .
This is a possibility, but whether your partner actually carries it and reinfects you will depend on whether his immune system can clear the infection.
Much remains unknown about HPV transmission when symptoms (lesions such as warts or cell changes) aren’t present, so experts cannot fully answer this question. However, studies show that in most cases a healthy immune system will eventually clear an HPV infection. Unfortunately, in some cases an infection may persist for years and result in recurrent abnormalities, however, this is very rare and an exception to the norm. In research studies, most people who test positive for a genital HPV infection eventually test negative, often within a year or two.
Many researchers and clinicians say the chances of transmitting the virus years after the last clinical episode (where warts or cervical abnormalities were detected) becomes reduced over time. This is not easy to prove and the lack of a solid "yes or no" answer makes it difficult to answer this question. Still, HPV does not seem likely to always be active.
- Winter RL et al., 2003. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. American Journal of Epidemiology, 157 (3), 218-226.
- Giulano AR et al., 2008. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26 (10), K17-28.
- Cancer Research UK website: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/cervix/ris.... Accessed 30/04/13.
- Schwarz TF and Leo O. 2008. Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature. Gynecological Oncology, 110 (3,1), S1-10.
- Safaeian M et al., 2010. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and 18 infections. Costa Rican Vaccine Trial Group. Journal of the National Cancer Institute 102(21), 1653-62.
- Szarewski et al., 2012. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer 131(1):106-16.
- Hauptt R et al., 2011. Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. FUTURE I and II Investigators. International Journal of Cancer. 129(11), 2632-42.
"FAQ on HPV." Jo's Cervical Cancer Trust. N.p., 19 Aug. 2013. Web. 02 Mar. 2015.